-
2
-
-
0027191820
-
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer
-
(1993)
J Clin Oncol
, vol.11
, pp. 1132-1137
-
-
Peters, W.1
Ross, M.2
Vredenburgh, J.3
Meisenberg, B.4
Marks, L.5
Winer, E.6
Kurtzberg, J.7
Jones, R.8
Schpall, E.9
Wu, K.10
Rosner, G.11
Gilbert, C.12
Mathias, B.13
Coniglio, D.14
Petros, W.15
Henderson, I.16
Norton, L.17
Weiss, R.18
Budman, D.19
Hurd, D.20
more..
-
5
-
-
9444243905
-
Evidence of a graft-versus -tumor effect in a patient treated with a marrow ablative chemotherapy and allogenic bone marrow transplantation for breast cancer
-
(1996)
Blood
, vol.4
, pp. 1501-1508
-
-
Eibl, B.1
Schawaighofer, H.2
Nachbaur, D.3
Marth, C.4
Gachter, A.5
Knapp, R.6
Bock, G.7
Gassner, C.8
Schiller, L.9
Petersen, F.10
Niederwieser, D.11
-
7
-
-
0025934169
-
High-dose recombinant interleukine-2 and acute myeloid leukemia in relapse
-
(1991)
Blood
, vol.78
, pp. 2182-2187
-
-
Maraninchi, D.1
Blaise, D.2
Viens, P.3
Brandely, M.4
Olive, D.5
Lopez, M.6
Sainty, D.7
Marit, G.8
Stoppa, A.9
Reiffers, J.10
Gratecos, N.11
Bertau Perez, P.12
Mannoni, P.13
Mawas, C.14
Hercend, T.15
Sebahoun, G.16
Carcassone, Y.17
-
8
-
-
0023115642
-
A progress report on the treatment of 157 patients with advanced cancer using activated killer cells and interleukine-2 or high dose interleukine-2 alone
-
(1987)
N Engl J Med
, vol.316
, pp. 889-897
-
-
Rosenberg, A.1
Lotze, M.2
Muul, L.3
Chang, A.4
Avis, F.5
Leitman, S.6
Linehan, M.7
Robertson, M.8
Lee, R.9
Rubin, J.10
Seipp, C.11
Simpson, C.12
White, D.13
-
10
-
-
0024514025
-
Endogenously generated activated killer cells circulate after autologous and allogenic marrow transplantation but not after chemotherapy
-
(1989)
Blood
, vol.73
, pp. 1351-1358
-
-
Reittie, J.1
Gottlieb, D.2
Heslop, H.3
Leger, O.4
Drexler, H.5
Hazlehurst, G.6
Hoffbrand, A.7
Prentice, H.8
Brenner, M.9
-
11
-
-
6444245790
-
The use of sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remission
-
(1997)
Leukemia and Lymphoma
, vol.25
, pp. 469-478
-
-
Blaise, D.1
Attal, M.2
Pico, J.3
Reiffers, J.4
Stoppa, A.5
Bellanger, C.6
Molina, L.7
Nedellec, G.8
Vernant, J.9
Legros, M.10
Gabus, R.11
Huguet, F.12
Brandely, M.13
Hercend, T.14
Olive, D.15
Maraninchi, D.16
-
12
-
-
0026115787
-
Recombinant interleukin-2 (rIL-2) after autologous bone marrow transplantation (BMT): A pilot study in 19 patients
-
(1991)
Eur Cytokine Net
, vol.2
, pp. 121-129
-
-
Blaise, D.1
Viens, P.2
Olive, D.3
Stoppa, A.4
Gabert, J.5
Pourreau, C.6
Attal, M.7
Gaspard, M.8
Mannoni, P.9
Jasmin, C.10
Palmer, P.11
Franks, C.12
Michel, G.13
Mawas, C.14
Baume, D.15
Philip, T.16
Maraninchi, D.17
-
13
-
-
0025040166
-
Hematologic and immunologic effects of the sytemic administration of recombinant interleukin-2 after autologous bone marrow transplantation
-
(1990)
Blood
, vol.76
, pp. 1092-1097
-
-
Blaise, D.1
Olive, D.2
Stoppa, A.3
Viens, P.4
Pourreau, C.5
Lopez, M.6
Attal, M.7
Jasmin, C.8
Monges, G.9
Mawas, C.10
Mannoni, P.11
Palmer, P.12
Franks, C.13
Philip, T.14
Maraninchi, D.15
-
14
-
-
6844239545
-
Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantation
-
(1997)
Eur Cytokine Net
, vol.8
, pp. 389-394
-
-
Vey, N.1
Viens, P.2
Fossat, C.3
Olive, D.4
Sainty, D.5
Baume, D.6
Stoppa, A.7
Bouabdallah, R.8
Brandely, M.9
Gastaut, J.10
Maraninchi, D.11
Blaise, D.12
-
15
-
-
13344287037
-
A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomas
-
(1996)
Leukemia and Lymphoma
, vol.21
, pp. 107-114
-
-
Vey, N.1
Blaise, D.2
Tiberghien, P.3
Attal, M.4
Pico, J.5
Reiffers, J.6
Harrousseau, J.7
Fiere, D.8
Tabilio, A.9
Gabus, R.10
Brandely, M.11
Maraninchi, D.12
-
16
-
-
0032917441
-
Immunotherapy with interleukin-2 and alpha-interferon after IL-2 activated hematopoietic stem cell transplantation for breast cancer
-
(1999)
Bone Marrow Transplant
, vol.23
, pp. 667-673
-
-
Meehan, K.1
Arun, B.2
Gehan, E.3
Berberian, B.4
Sulica, V.5
Areman, E.6
Mazumder, A.7
Lippman, M.8
-
18
-
-
0026528464
-
Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantation
-
(1992)
Br J Cancer
, vol.65
, pp. 399-404
-
-
Richard, B.1
Launay-Iliadis, M.2
Iliadis, A.3
Just-Landi, S.4
Blaise, D.5
Stoppa, A.6
Viens, P.7
Gaspard, M.8
Maraninchi, D.9
Cano, J.10
Carcassone, Y.11
-
19
-
-
0027510415
-
Lowest dose interleukin-2 immunotherapy
-
(1993)
Blood
, vol.81
, pp. 1414-1423
-
-
Smith, K.1
-
20
-
-
0026512503
-
Clinical and immunological effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell depleted allogenic bone marrow transplantation
-
(1992)
Blood
, vol.79
, pp. 517-526
-
-
Soiffer, R.1
Murray, C.2
Cochran, K.3
Cameron, C.4
Wang, E.5
Schow, P.6
Daley, J.7
Ritz, J.8
-
21
-
-
0025991319
-
Intravenous interleukin-2 just after high dose BCNU and autologous bone marrow transplantation. Report of a multicentric French pilot study
-
(1991)
Bone Marrow Transplant
, vol.8
, pp. 259-264
-
-
Negrier, S.1
Ranchere, J.2
Philip, I.3
Biron, P.4
Blaise, D.5
Attal, M.6
Rebattu, P.7
Clavel, M.8
Pourreau, C.9
-
23
-
-
0030668728
-
Interleukin-2 activated hematopoietic stem cell transplantation for breast cancer: Investigation of dose level with clinical correlates
-
(1997)
Bone Marrow Transplant
, vol.20
, pp. 643-651
-
-
Meehan, K.1
Verma, U.2
Cahill, R.3
Frankel, S.4
Areman, E.5
Sacher, R.6
Foebler, R.7
Rajagapol, C.8
Gehan, E.9
Lippman, M.10
Mazumder, A.11
|